Johns Hopkins Sidney Kimmel Cancer Center announced Monday that it has established a Center for Personalized Cancer Medicine with a $30 million gift from the Richmond, Va.-based Commonwealth Foundation for Cancer Research.
The money will further Hopkins' research into technologies that can pinpoint genetic characteristics of a patient's cancer so therapies can be tailor-made.
"Treatment fine-tuned to a patient's genetic makeup is the future of cancer medicine," said Ronald J. Daniels, president of the Johns Hopkins University. "This gift is welcome recognition that Johns Hopkins is bringing together experts from many disciplines — doctors, scientists and engineers — to make that future happen more quickly."
The aim is to avoid hit-and-miss and one-size-fits-all approaches for the annual 1.5 million Americans diagnosed with cancer, to use the right drugs for treatment, and even prevent some cancers.
The Commonwealth Foundation for Cancer Research previously donated $40 million to support other research at Hopkins, including a trial using bacteria to treat colon cancer, a targeted vaccine to treat pancreatic and breast cancers, and cancer stem cell research.